Hong Kong Pharma Digital Technology Holdings Limited (HKPD) Earnings History
Net Loss3 years of earnings data (2023–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) Earnings Overview
As of June 29, 2026, Hong Kong Pharma Digital Technology Holdings Limited (HKPD) reported trailing twelve-month net income of -$27,056, reflecting -101.7% year-over-year growth. The company earned $-0.00 per diluted share over the past four quarters, with a net profit margin of -0.1%.
Looking at the long-term picture, HKPD's historical earnings data spans multiple years. The company achieved its highest annual net income of $1M in fiscal 2024.
Hong Kong Pharma Digital Technology Holdings Limited is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ATXG (-$7M net income, -121.8% margin), CNET (-$1M net income, -38.4% margin), BTBT (-$169M net income, -70.7% margin), HKPD has outperformed on profitability metrics. Compare HKPD vs ATXG →
HKPD Earnings vs Peers
Earnings metrics vs comparable public companies
HKPD Historical Earnings Data (2023–2025)
3 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $-27,056 | -102.0% | $132,038 | $-0.00 | -0.1% | 0.6% |
| 2024 | $1M | +33.2% | $2M | $0.18 | 8.0% | 9.6% |
| 2023 | $998,196 | - | $1M | $0.09 | 7.9% | 8.3% |
Download Data
Export HKPD earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
3+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
HKPD — Frequently Asked Questions
Quick answers to the most common questions about buying HKPD stock.
What is HKPD earnings per share (EPS)?
HKPD trailing twelve-month (TTM) diluted EPS is $-0.00, reflecting -101.7% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2023 to 2025 is available in the table on this page.
What is Hong Kong Pharma Digital Technology Holdings Limited's net income?
Hong Kong Pharma Digital Technology Holdings Limited (HKPD) trailing twelve-month net income is $-27056.00 as of 2025. Earnings declined -101.7% year-over-year.
Is HKPD profitable?
HKPD is not currently profitable on a TTM basis, reporting a net loss of $-27056.00. Net margin is -0.1%. Investors should monitor for a return to profitability.
What is HKPD's earnings growth rate?
HKPD compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2023 to 2025.
What are HKPD's profit margins?
Hong Kong Pharma Digital Technology Holdings Limited net profit margin is -0.1%, operating margin is +0.7%, and gross margin is +11.9%. Below-average margins reflect competitive or cost pressures. Return on Equity is -0.6%.
Is HKPD growing earnings?
HKPD earnings are declining — EPS fell -101.7% year-over-year. TTM net income dropped to $-27056.00. This contrasts with the 5-year CAGR of N/A.
What was HKPD's best earnings year?
Hong Kong Pharma Digital Technology Holdings Limited's highest annual net income on record is $1M, achieved in fiscal year 2024. Earnings history on this page spans 2023 to 2025 and includes all annual and quarterly figures.
What were HKPD's earnings last quarter?
HKPD's most recent reported quarter was Q4 2025. Net income was $-855616.00 with diluted EPS of $-0.08. For a full breakdown of all quarters, see the quarterly earnings table on this page.